The growing role of PROs in drug development
Posted February 03, 2016
After years as a staple in clinical trials, patient-reported outcomes (PROs) are experiencing an expanded role in the drug discovery and development process.
For years, pharmaceutical companies have used PROs during clinical trials to help measure the impact and effectiveness of their drugs. More recently, drug developers have found that PROs can be used throughout the entire drug development lifecycle to identify new markets, engage patients who may benefit from the new drug, and convince payers of the new drug’s value.
Watch this recorded webinar to learn how PROs are being used to identify new markets and engage patients in exciting new ways.